Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$187.0K
645.00 shares
What this filing means
MESA NILDA plans to sell 645.00 shares of UNITED THERAPEUTICS CORP valued at approximately $187.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/24/2025ACC: 0001950047-25-004594
645.00
Shares to sell
$187.0K
Approx. market value
645.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/13/2024
645.00Total acquired645.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/13/2024 | Restricted Stock Not Applicable | 645.00 | — |
| Total | 645.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
645.00
Market value
$187.0K
6/24/2025
Total
Units
645.00
Value
$187.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/24/2025 | 645.00 | $187.0K | NASDAQ | Planned |
| Total | 645.00 | $187.0K | ||